Evidence map›Paper›PMID 31615930›Full record

ArticleJournal of virology2019

Correction for Kibler et al., "Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC".

Karen V Kibler, Benedikt Asbach, Beatriz Perdiguero, Juan García-Arriaza, Nicole L Yates, Robert Parks, Sherry Stanfield-Oakley, Guido Ferrari, David C Montefiori, Georgia D Tomaras and 18 more

Open access · hybridAbstract readPublished Erratum
In one paragraph

Article in Journal of virology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 5 countries.

Karen V KiblerBiodesign Institute, Arizona State University, Tempe, Arizona, USA.
Benedikt AsbachInstitute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Beatriz PerdigueroDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Juan García-ArriazaDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Nicole L YatesDuke University Medical Center, Durham, North Carolina, USA.
Robert ParksDuke University Medical Center, Durham, North Carolina, USA.
Sherry Stanfield-OakleyDuke University Medical Center, Durham, North Carolina, USA.
Guido FerrariDuke University Medical Center, Durham, North Carolina, USA.
David C MontefioriDuke University Medical Center, Durham, North Carolina, USA.
Georgia D TomarasDuke University Medical Center, Durham, North Carolina, USA.
Mario RoedererVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kathryn E FouldsVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Donald N ForthalDivision of Infectious Diseases Department of Medicine, Irvine School of Medicine, University of California, Irvine, California, USA.
Michael S SeamanCenter for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Steve SelfStatistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Raphael GottardoStatistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Sanjay PhogatSanofi Pasteur, Swiftwater, Pennsylvania, USA.
James TartagliaSanofi Pasteur, Swiftwater, Pennsylvania, USA.
Susan BarnettNovartis Vaccines and Diagnostics, Inc., Cambridge, Massachusetts, USA.
Anthony D CristilloAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Deborah WeissAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Lindsey GalminAdvanced BioScience Laboratories, Inc., Rockville, Maryland, USA.
Song DingEuroVacc Foundation, Lausanne, Switzerland.
Jonathan L HeeneyLab of Viral Zoonotics, Department of Veterinary Medicine, University of Cambridge, Cambridge, United Kingdom.
Mariano EstebanDepartment of Molecular and Cellular Biology, Centro Nacional de Biotecnología, Consejo Superior de Investigaciones Científicas, Madrid, Spain.
Ralf WagnerInstitute of Medical Microbiology and Hygiene, University of Regensburg, Regensburg, Germany.
Giuseppe Pantaleo
Bertram L JacobsBiodesign Institute, Arizona State University, Tempe, Arizona, USA.
Duke Medical Center · USArizona State University · USBioScience Laboratories (United States) · USCentro Nacional de Biotecnología · ESFred Hutch Cancer Center · USNational Institute of Allergy and Infectious Diseases · USSanofi (United States) · USAdvanced Bioscience Laboratories (United States) · USBeth Israel Deaconess Medical Center · USConsejo Superior de Investigaciones Científicas · ESEurovacc Foundation · CHInstitute of Medical Microbiology and Hygiene · DENovartis (United States) · USUniversity of California, Irvine · USUniversity of Cambridge · GBUniversity of Regensburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID31615930
PMCPMC6803259
OpenAlexW2980446712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.